Furthermore, this PhoXCELL strategy allowed to simultaneously detect tumor antigen-specific CD8+ and CD4+ T cells from tumor-infiltrating lymphocytes and draining lymph nodes in preclinical mouse models. The gene discussed is CD4; the disease is neoplasm.